These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 6605139

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR, Jones D, Reba RC, Mann U, Coppola R, Gibson R, Gorey J, Braun A, Chase TN.
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [Abstract] [Full Text] [Related]

  • 23. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study.
    Brunetti A, Berg G, Di Chiro G, Cohen RM, Yarchoan R, Pizzo PA, Broder S, Eddy J, Fulham MJ, Finn RD.
    J Nucl Med; 1989 May; 30(5):581-90. PubMed ID: 2785582
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E.
    J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
    [Abstract] [Full Text] [Related]

  • 26. 18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
    McGeer EG, Peppard RP, McGeer PL, Tuokko H, Crockett D, Parks R, Akiyama H, Calne DB, Beattie BL, Harrop R.
    Can J Neurol Sci; 1990 Feb; 17(1):1-11. PubMed ID: 2311010
    [Abstract] [Full Text] [Related]

  • 27. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE, Metter EJ, Riege WH.
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [Abstract] [Full Text] [Related]

  • 28. NIH Conference. Brain imaging: aging and dementia.
    Cutler NR, Duara R, Creasey H, Grady CL, Haxby JV, Schapiro MB, Rapoport SI.
    Ann Intern Med; 1984 Sep; 101(3):355-69. PubMed ID: 6235763
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography.
    Blin J, Piercey MF, Giuffra ME, Mouradian MM, Chase TN.
    J Neurol Sci; 1994 May; 123(1-2):44-51. PubMed ID: 8064320
    [Abstract] [Full Text] [Related]

  • 32. Patterns of human local cerebral glucose metabolism during epileptic seizures.
    Engel J, Kuhl DE, Phelps ME.
    Science; 1982 Oct 01; 218(4567):64-6. PubMed ID: 6981843
    [Abstract] [Full Text] [Related]

  • 33. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, Coleman RE.
    J Nucl Med; 2000 Nov 01; 41(11):1920-8. PubMed ID: 11079505
    [Abstract] [Full Text] [Related]

  • 34. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.
    Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, Alavi J, Reivich M.
    J Nucl Med; 1987 Nov 01; 28(11):1667-70. PubMed ID: 3499490
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Positron emission tomography in Alzheimer's disease.
    Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI.
    Neurology; 1986 Jul 01; 36(7):879-87. PubMed ID: 3487046
    [Abstract] [Full Text] [Related]

  • 39. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.
    Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE.
    J Nucl Med; 1995 Dec 01; 36(12):2207-10. PubMed ID: 8523106
    [Abstract] [Full Text] [Related]

  • 40. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E.
    J Nucl Med; 1998 Nov 01; 39(11):1875-8. PubMed ID: 9829574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.